Australia: Overview of the regulatory framework for in-vitro diagnostic medical devices
17/7/2011
A new regulatory framework which commenced on 1 July 2010 ensures that all IVDs will undergo a level of regulatory scrutiny that is commensurate with the risks associated with their use. The legislation incorporates accepted best practice relating to safety, quality and risk management procedures, and provides the flexibility and capacity to regulate new and changing technology and emerging diseases.
Under the new framework IVDs are regulated as a subset of medical devices. The Therapeutic Goods Regulations (Medical Devices) 2002 have been amended to include IVDs.
Author: Greer Deal, Director of Global Regulatory Services (GRS)